Registered Charity No. 1088008.
  Andropause
  Lectures
  Primary Care  
 

International  

 

Reviews

 

Lay Forum

 

Reference Library

 

Bibliography 

  Other News
  Payments
  Member Search
  Edit your details
 
  Conference 2005
  Conference 2003
  Training
 
  Events Diary
   
 
Help Centre - Questionnaire, Forum, Doctors, Books
 
  Legal
  Contact
  Search the Site

 

Canada Latest News from the Canadian Andropause Society  
Australia The Andropause Society of Australia and the fight for HRT  
USA Developments in USA

THE FIGHT FOR MALE HRT IN AUSTRALIA - BACKGROUND

The Andropause Society of Australia

The fight for HRT in Australia

The legal proceedings

A test case

Linda Byart

Situation Prior to August 1999

Testosterone supplementation was available to men on subsidy under the Pharmaceutical Benefits Scheme (PBS) where, in the doctor’s opinion, the man was ‘hypogonadal’. This diagnosis was reached by the doctor from consideration of the man’s presenting symptoms and supported by reference to pathology from blood tests taken.

At that time most laboratories would provide guidance to doctors defining the reference range of serum (total) testosterone of 11 nmols —35 nmols as being ‘within normal limits’ or ‘within normal range’. So if a man was at the lower end of the range and certainly if he was off the bottom end of the scale, and he had a range of characteristic symptoms, then doctors could obtain an authority prescription for testosterone replacement medication on subsidy under the PBS.

In fact, because most GP’s have received little or no formal training in the operation of hormones in men, relatively few doctors were even considering hormones as a possible cause factor, so few investigations were taking place.

Amendments brought in August 1999

These amendments, which FOI documents reveal were intended to increase restriction on access to hormone supplementation, for men only, removed any role for the man’s treating doctor in the diagnostic process of his condition and eliminated consideration of a man’s symptoms entirely.

Instead, outside of a few defined exceptions, the government introduced a rigid biochemical criteria whereby two morning blood samples of serum testosterone, taken on different mornings, must show results of 8 nmols or less for a man to qualify for subsidy on medication under the PBS.

Did this break the law?

From a legal standpoint we understand that both the government and the consultative committee in relation to the PBS the Pharmaceutical Benefits Advisory Committee (PBAC) — have the right o be wrong medically.

The pertinent question in relation to appeals to the Federal Court is whether the law has been broken by the introduction of these rules and their subsequent implementation.

We strongly believe that with proper legal representation, there is evidence available to show that the law has been broken on three counts le that the government and PEAC have breached the following:

1. The Sexual Discrimination Act

2. The international Covenant on Civil and Political Rights (ICCPR)

3. The Administrative Decisions (Judicial Review Act) 1977